Crescendo Health, a real-world data firm, debuted this month with $3.4 million from Define Ventures and other investors. The startup’s goal is to collect longitudinal data for clinical research, including information from other healthcare contacts that may not be obtained if patients choose not to participate in a trial.
Related post: Royal College of Radiologists and xWave collaborate to reduce data pile-up
To supply other health data, the firm collaborates with biopharma companies, medical device makers, and contract research groups. It translates the data into a format suitable for researchers and returns it to participants via a patient portal. The cash will be used by the business to develop software that will allow its life science partners to investigate the long-term impacts of therapy and follow patient results.
